Baseline type 2 biomarker levels and response to tezepelumab in severe asthma. Corren J, Pham TH, Gil EG, Salapa K, et al. Allergy 2021 Dec 16. doi: 10.1111/all.15197.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Corren J, Pham TH, Gil EG, Salapa K, et al. Baseline type 2 biomarker levels and response to tezepelumab in severe asthma. Allergy 2021 Dec 16. doi: 10.1111/all.15197.
PMID: 34913186